Influence of BMI on Serum Adiponectin, Resistine, and FBG among Overweight and Obese Females Diabetic Patient Type2

Authors

  • Salah Eldin Omar Hussein Department of Medical Laboratory Sciences, College of Health Sciences, Gulf Medical University, Ajman, United Arab Emirates
  • Abd Elgadir Alamin Altoum Department of Medical Laboratory Sciences, College of Health Sciences, Gulf Medical University, Ajman, United Arab Emirates
  • Ahmed L. Osman Department of Medical Laboratory Sciences, College of Health Sciences, Gulf Medical University, Ajman, United Arab Emirates
  • Hassan M. K. I. Higazi Department of Medical Laboratory Sciences, College of Health Sciences, Gulf Medical University, Ajman, United Arab Emirates
  • Sara Ali Department of Medical Laboratory Sciences, College of Health Sciences, Gulf Medical University, Ajman, United Arab Emirates
  • Ayman Hussien Alfeel Department of Medical Laboratory Sciences, College of Health Sciences, Gulf Medical University, Ajman, United Arab Emirates

DOI:

https://doi.org/10.3889/oamjms.2022.9652

Keywords:

Obese, Overweight, Body mass index, Fasting blood glucose, Adiponectin and Resistine

Abstract

Abstract:

Background and aim: Obesity is a frequent comorbidity in patients with T2DM and it has been estimated that at least 90% of these patients are overweight or obese.[4] The risks of many complications and comorbidities (e.g., cardiovascular disease and chronic kidney disease) are considerably increased in patients with T2DM who have concomitant obesity. In this study evaluation the level of Resistine, Fasting Blood Glucose and Adiponectin in overweight, obese versus normal weight, females. Compare with the BMI. Methods: A descriptive cross-sectional - case-control study, the target population is a total 204 Sudanese females were recruited to participate in this study (102 overweight, obese versus 102 non-overweight, non-obese), aged 20-50 years. and venous blood samples were collected. Plasma levels of blood glucose were measured using the particle-enhanced immunoturbidimetric assay method Cobas C-311®.While Adiponectin and Resistine estimated by ELISA Kits. Anthropometric measurements, including height and weight, were taken using standard protocols. BMI was calculated as weight (in kilograms) divided by height (in meters squared). Results: According to these results observed significant difference between the means of fasting blood glucose (FBG), adiponectin, Resistine and BMI compare with normal weight, overweight and obese respectively. FBG (mean + SD), normal weight (127 ± 16.7), over weight (153 ± 19.2), obese (189 ± 22.7), P = 0.037, adiponectin, (11.2 ± 1.9), (9.7 ± 1.6), (6.1 ± 1.5), P = 0.043, Resistine, (12.8 ± 1.1) ,(14.2 ± 2.7), (18.2 ± 2.9), P = 0.021, BMI, (18.3 ± 1.7) ,(26.1 ± 2.2), (30.4 ± 3.7), P = 0.006.  In this study, the results show strong negative Correlation between the levels of serum Adiponectin and Fasting Blood Glucose, Adiponectin and Resistine. (P.value = 0.013, r = -7.9). (P.value = 0.019, r = -6.6). While showing in the other side strong positive Correlation between the levels of serum Resistine and Fasting Blood Glucose. (P.value = 0.015, r = 6.0).

Conclusion: Increase of Resistine and Fasting Blood Glucose and reduced of Adiponectin in overweight, obese versus non-overweight, non-obese females. Compare with the BMI.

Keywords: Obese, Overweight, BMI, FBG, Adiponectin and Resistine

Downloads

Download data is not yet available.

Metrics

Metrics Loading ...

Plum Analytics Artifact Widget Block

References

Kershaw EE, Flier JS. Adipose tissue as an endocrine organ. J Clin Endocrinol Metab. 2004;89:2548-56. PMid:15181022 DOI: https://doi.org/10.1210/jc.2004-0395

Kocot J, Dziemidok P, Kiełczykowska M, Hordyjewska A, Szcześniak G, Musik I. Adipokine profile in patients with type 2 diabetes depends on degree of obesity. Med Sci Monit. 2017;23:4995-5004. https://doi.org/10.12659/msm.904318 PMid:29049270 DOI: https://doi.org/10.12659/MSM.904318

Lee SH. Adipokine profiles and metabolic health. Endocrinol Metab (Seoul) 2015;30:175-6. PMid:26194077 DOI: https://doi.org/10.3803/EnM.2015.30.2.175

Alberti KG, Zimmet P, Shaw J. The metabolic syndrome--a new worldwide definition. Lancet. 2005;366(9491):1059-62. https://doi.org/10.1016/s0140-6736(05)67402-8 PMid:16182882 DOI: https://doi.org/10.1016/S0140-6736(05)67402-8

Kusminski CM, Scherer PE. The road from discovery to clinic: Adiponectin as a biomarker of metabolic status. Nature. 2009;86:592-5. https://doi.org/10.1038/clpt.2009.155 PMid:19915603 DOI: https://doi.org/10.1038/clpt.2009.155

Kowalska I. Role of adipose tissue in the development of vascular complications in type 2 diabetes mellitus. Diabetes Res Clin Pract. 2007;78:14-22. https://doi.org/10.1016/j.diabres.2007.10.007 DOI: https://doi.org/10.1016/j.diabres.2007.10.007

Chen BH, Song Y, Ding EL, Roberts CK, Manson JE, Rifai N, et al. Circulating levels of resistin and risk of type 2 diabetes in men and women: Results from two prospective cohorts. Diabetes Care. 2009;32(2):329-34. https://doi.org/10.2337/dc08-1625 PMid:18957529 DOI: https://doi.org/10.2337/dc08-1625

Yamauchi T, Kamon J, Minokoshi Y, Ito Y, Waki H, Uchida S, et al. Adiponectin stimulates glucose utilization and fatty-acid oxidation by activating AMP-activated protein kinase. Nat Med. 2010;8:1288-95. https://doi.org/10.1038/nm788 PMid:12368907 DOI: https://doi.org/10.1038/nm788

Matsuzawa Y. Adiponectin: Identification, physiology and clinical relevance in metabolic and vascular disease. Atheroscler Suppl. 2005;6(2):7-14. https://doi.org/10.1016/j.atherosclerosissup.2005.02.003 PMid:15823491 DOI: https://doi.org/10.1016/j.atherosclerosissup.2005.02.003

Hotta K, Funahashi T, Arita Y, Takahashi M, Matsuda M, Okamoto Y, et al. Plasma concentrations of a novel, adipose-specific protein, adiponectin, in type 2 diabetic patients. Arterioscler Thromb Vasc Biol. 2000;20(6):1595-9. https://doi.org/10.1161/01.atv.20.6.1595 PMid:10845877 DOI: https://doi.org/10.1161/01.ATV.20.6.1595

Houston GW. The prevalence of diabetes mellitus ina typical English community. J R Coll Physicians Lond. 1985;19(4):248-50. PMid:4067900

Cancello R, Tounian A, Poitou C, Clement K. Adiposity signals, genetic and bodweight regulation in humans. Diabetes Metab. 2004;30(3):215-27. https://doi.org/10.1016/s1262-3636(07)70112-x PMid:15223973 DOI: https://doi.org/10.1016/S1262-3636(07)70112-X

McKeigue PM, Ferrie JE, Pierpoint T, Marmot MG. Association of early-onset coronary heart disease in South Asian men with glucose intolerance and hyperinsulinemia. Circulation. 1993;87(1):152-61. https://doi.org/10.1161/01.cir.87.1.152 PMid:8419002 DOI: https://doi.org/10.1161/01.CIR.87.1.152

Valsamakis G, Chetty R, McTernan PG, Al-Daghri NM, Barnett AH, Kumar S. Fasting adiponectin concentration is reduced in Indo-Asian subjects and is related to HDL cholesterol. Diabetes Obes Metab. 2003;5:131-5. https://doi.org/10.1046/j.1463-1326.2003.00254.x PMid:12630939 DOI: https://doi.org/10.1046/j.1463-1326.2003.00254.x

Downloads

Published

2022-05-23

How to Cite

1.
Hussein SEO, Altoum AEA, Osman AL, Higazi HMKI, Ali S, Alfeel AH. Influence of BMI on Serum Adiponectin, Resistine, and FBG among Overweight and Obese Females Diabetic Patient Type2. Open Access Maced J Med Sci [Internet]. 2022 May 23 [cited 2024 Mar. 29];10(B):1218-21. Available from: https://oamjms.eu/index.php/mjms/article/view/9652

Most read articles by the same author(s)